CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −320 | $540.04 | $173K | 18,876 |
| 2026-03-26 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 142,500 | ||
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −159 | $530.95 | $84K | 49,854 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −841 | $532.08 | $447K | 49,013 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −498 | $532.90 | $265K | 48,515 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −837 | $534.02 | $447K | 47,678 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,476 | $535.06 | $790K | 46,202 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,029 | $536.00 | $1.1M | 44,173 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,540 | $536.96 | $827K | 42,633 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,100 | $537.97 | $592K | 41,533 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −740 | $538.90 | $399K | 40,793 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $539.98 | $151K | 40,513 |
| 2026-03-26 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 59,500 | ||
| 2026-03-26 | Thompson Tommy G Director | Option exercise | +2,000 | $101.80 | $204K | 10,480 |
| 2026-03-26 | Thompson Tommy G Director | Sale | −275 | $537.62 | $148K | 10,205 |
| 2026-03-26 | Thompson Tommy G Director | Sale | −1,414 | $539.25 | $762K | 8,791 |
| 2026-03-26 | Thompson Tommy G Director | Sale | −311 | $540.18 | $168K | 8,480 |
| 2026-03-26 | Thompson Tommy G Director | Option exercise · Stock Option | −2,000 | 0 | ||
| 2026-03-25 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
Page 139 of 171 · 3,408 trades